This study examined whether expectancy of ergogenicity of a commonly used nutritional supplement (sodium bicarbonate; NaHCO 3 ) influenced subsequent high-intensity cycling capacity. Eight recreationally active males lower for SHAM compared to PLA (P=0.020, d=0.6). There were no differences between treatments for blood lactate, blood glucose or heart rate.
This study examined whether expectancy of ergogenicity of a commonly used nutritional supplement (sodium bicarbonate; NaHCO 3 ) influenced subsequent high-intensity cycling capacity. Eight recreationally active males (age: 21±1 years, body mass: 75±8 kg, height: 178±4 cm, W PEAK : 204±23 W) performed a graded incremental test to assess peak power output (W PEAK ), one familiarisation trial and two experimental trials. Experimental trials consisted of cycling at 100% W PEAK to volitional exhaustion (T LIM ) 60 min after ingesting either a placebo (PLA; 0.1 g.kg -1 sodium chloride (NaCl), 4 ml.kg -1 tap water and 1 ml.kg -1 squash) or a sham placebo (SHAM; 0.1 g.kg -1 NaCl, 4 ml.kg -1 carbonated water and 1 ml.kg -1 squash). SHAM aimed to replicate D r a f t Introduction A significant amount of research has examined the efficacy of sodium bicarbonate (NaHCO 3 ) as an ergogenic aid (Cameron et al. 2010; Krustrup et al. 2015; Lavender and Bird 1989; Price and Simons 2010; Tan, et al. 2010) . Cameron et al. (2010) reported that ingestion of 0.3 g.kg -1 NaHCO 3 60 min prior to exercise had no effect on multiple indices of repeated sprint performance in elite rugby players. Cameron et al. (2010) suggested the most likely reason for the lack of performance enhancement was due to the higher frequency and greater severity of gastrointestinal (GI) symptoms after NaHCO 3 ingestion. However, the lack of performance improvement might also have been influenced by the trained nature of participants with Peart et al. (2012) reporting that untrained individuals are significantly more likely to experience ergogenic benefit with NaHCO 3 . Indeed it is now well established that individuals who undertake high-intensity training have elevated levels of muscle carnosine compared with endurance trained and untrained individuals (Parkhouse and McKenzie 1984; Parkhouse et al. 1985) . As carnosine is thought to play an important role in the homeostasis of muscle cells during high-intensity exercise (as an intracellular buffer) greater basal levels might 'offset' any potential ergogenic contribution from augmented extracellular NaHCO 3 (Aschenbach et al. 2000; Derave et al. 2010 ).
In support of this, Higgins et al. (2013) According to Clark et al. (2000; pg 1642) , the placebo effect is "...a favourable outcome arising purely from belief that one has received a beneficial treatment..." Expectancy is closely associated and in some instances assumed to have a direct relationship with the placebo effect (Kirsch 1985) . It is suggested by enhancing the degree of expectancy, subsequently ones belief in the effectiveness of the placebo might increase (Evans 2003) . The effects of expectancy on sport and exercise performance has been evaluated in a variety of different experimental models (Broatch et al. 2014; Maganaris et al. 2000; McClung and Collins 2007; Ross et al. 2015) . For example, Maganaris et al., (2000) administered a saccharine placebo to eleven national level power lifters but provided false information to enhance expectancy of performance benefit. Participants were led to believe that they had consumed anabolic steroids which resulted in changes from baseline of 10±2 kg, 11±2 kg and 12±1 kg, for maximal bench press, dead lift and squat performance, respectively. However, when approximately half of the group were told the true nature of the placebo these performance gains almost completely dissipated although remained for the group who believed they had consumed anabolic steroids (Maganaris, et al. 2000) .
To the best of our knowledge, only one study has previously evaluated the effects of expectancy on exercise performance with respect of NaHCO 3 ingestion (McClung and Collins 2007) . Sixteen trained endurance athletes ran 5 x 1000 m time trials after ingesting either sodium bicarbonate (NaHCO 3 ) or a placebo in combination with being told correctly or deceived regarding what treatment had been administered (i.e. told NaHCO 3 /placebo, given/not given NaHCO 3 /placebo). The told NaHCO 3 /given placebo treatment performed the time trial significantly faster (-3.4 s / -1.8 %) than the told placebo/given NaHCO 3 treatment demonstrating the effects of expectancy on exercise performance were greater than the purely pharmacological effects of NaHCO 3 .
As there has been limited research on the potential psychobiological impact of NaHCO 3 administration on exercise performance (McClung and Collins 2007) and based on previous data that suggests GI distress does not necessarily negatively influence exercise performance (Higgins et al. 2013;  Price and Simons 2010) we speculated that replicating side effects of NaHCO 3 ingestion might initiate a degree of expectancy of ergogenicity which might influence exercise performance. Therefore, the aim of this study was to evaluate the effect of expectancy associated with NaHCO 3 ingestion on high intensity cycling capacity. We hypothesised that by increasing the expectancy of ergogenicity a relatively inert compound (NaCl) mimicked as closely as possible and described as NaHCO 3 would induce a significant increase in cycling capacity.
Materials and methods
Participants
Eight healthy and active male participants volunteered to take part in this study (age: 21±1 years, body mass: 75±8 kg, height: 178±4 cm) which received university ethics committee approval. All participants were recreationally active although not specifically cycle trained (W PEAK : 204±23 W). In order to maximise the integrity of the treatment deception all participants were pre-screened to ensure they had not used alkalotic buffers for a minimum of 3 months. Furthermore, no participants had ever previously consumed NaHCO 3 and only one had ever heard of its use with respect of sport and exercise performance.
Pre-experimental procedures
Participants were requested to avoid alcohol and strenuous exercise 12 and 24 hours prior to exercise, respectively. Participants were also requested to adopt the same balanced diet for 24 hours prior to each trial with adherence monitored via self-reported food diaries. Participants were specifically requested to avoid low carbohydrate intake which can induce mild metabolic acidosis and subsequently negatively affect exercise capacity (Greenhaff et al. 1988 ). The aforementioned information was included in the participant information sheet (PIS) and confirmed verbally before written consent was provided. Each participant completed physical activity readiness D r a f t 7 (PAR-Q) and blood screening questionnaires prior to the commencement of the study. Specifically, the blood screening questionnaire asked participants to report any serious infections, jaundice, haemophilia or anything that might be hazardous to the health of the participant or researcher. Individuals were only permitted to participate if they were deemed healthy and able to do so.
Participants attended the laboratory at the same time of the day for each visit to minimise the influence of circadian changes on exercise performance (Fernandes et al. 2014) . Trials were carried out 3 to 7 days apart.
Protocol
On the first visit to the laboratory, participants performed a graded incremental test to assess peak power output (W PEAK ) on a cycle ergometer (Lamberts et al. 2012) . If exhaustion occurred less than one minute into a stage the appropriate duration undertaken at each power output was used to calculate a pro-rata W PEAK (Higgins et al. 2013 ).
The second trial was a T LIM familiarisation at 100% W PEAK . After 5 min seated rest ratings of gut fullness (GF) and abdominal discomfort (AD) were recorded against an 11 point (0 to 10) scale with 0 representing 'empty' and 'completely comfortable', respectively and 10 representing 'bloated' and 'unbearable pain', respectively (Higgins et al. 2013) . A fingerpick capillary blood sample was then taken and analysed for [BLa] and blood glucose was used to assess RPE O which is deemed to have a linear relationship with work load, oxygen consumption and heart rate (Borg 1982) . In contrast, the 10 point (1-10) category-ratio scale (CR-10) was used to assess RPE L . This approach has been shown to correlate better with sensations associated with lactate accumulation (McClung and Collins 2007) . Further blood samples for
[BLa] and [BG] were taken at the end of exercise and 5 min post-exercise.
After final measurements had been collected and after completing a selfselected warm down participants left the laboratory.
On the third and fourth visits to the laboratory participants completed experimental trials which were identical to the aforementioned exercise protocol with the following amendments. Prior to treatment ingestion participants were provided with a written manuscript which detailed the proposed effects of the subsequent treatment. For PLA the manuscript suggested that NaCl was relatively inert and would have little impact on exercise performance, whereas for SHAM the 'proven' ergogenicity of NaHCO 3 was presented and in line with the AD and GF scales adopted the potential for associated feelings of GI distress such as build of gas and bloating were outlined. Participants then ingested either 0.1 g.kg -1 sodium chloride (NaCl) mixed with orange squash as previously described and either 4 ml.kg -1 tap water (placebo; PLA), or 4 ml. Bonferroni corrections were applied. In some instances an ANOVA was chosen despite the majority of data not being normally distributed (i.e. AD and GF). This was decided so as to minimise the potential for type-I error due to multiple individual (non-parametric) comparisons and because of the general robustness of the univariate ANOVA test to violations of normality (Schmider et al. 2010 was felt that actually administering NaHCO 3 to participants could render the SHAM treatment ineffective in enhancing expectancy due to participants associating more severe GI symptoms with 'genuine' NaHCO 3 ingestion (Cameron et al. 2010) . As such by comparing only PLA and SHAM, whose only differences were the information given pre-exercise and whether the water was tap or carbonated, we have been able to isolate the effects of preexercise information designed to increased expectancy of ergogenicity with NaHCO 3 ingestion on exercise capacity. It appears that this strategy has contributed to the observed increase in exercise capacity, at least in some individuals.
Compared with PLA RPE O was 1.4±1.3 units lower for SHAM after 3 min T LIM with the associated effect size (0.6) equivalent to a medium to large magnitude of change (Cohen 1988 (2007) who reported that RPE (based on perceptions of lactate accumulation and therefore most similar to RPE L in the present study) was 1.5 units lower for the told NaHCO 3 /given placebo trial compared to the told placebo/given placebo trial with the told NaHCO 3 /given placebo trial performing the 1 km time trial -2.8 s / -1.5% faster. Interestingly, both results D r a f t are similar to Higgins et al. (2013) who reported RPE L was 1.5 units lower after both 1 and 2 min of T LIM cycling at 100% W PEAK after NaHCO 3 ingestion.
Moreover, the authors reported significant correlations between T LIM and RPE L at the same time points. Therefore, it is plausible that reductions in RPE and any impact on exercise performance are not solely due to NaHCO 3 induced mediation of acid-base balance (i.e. the pharmacological effects).
These results are in accordance with the psychobiological model which suggests that reduced perception of effort can increase exercise performance (Ross et al. 2015; Smirmaul, et al. 2013 ) with perception of effort postulated as a key determinant of exercise tolerance (Marcora and Staiano 2010) . The reduction in perception of effort might be linked to the mediation of endogenous opioids via expectancy orientated placebo effects (Benedetti et al. 2005) .
In the present study the mean 9.5% (+40 s) increase in exercise capacity after SHAM is substantially larger than the -1.5 % (-2.8 s)
improvement for the placebo/told NaHCO 3 trial compared with the given placebo/told placebo trial reported by McClung and Collins (2007) . This is likely due to a number of methodological differences between studies such Taken together, these data suggest that these physiological variables did not contribute to the observed differences in T LIM .
To the best of our knowledge the daily variation for T LIM at 100% W PEAK in recreationally active participants is currently unknown. Therefore,
we have compared participant's individual data to the daily variation of ~ 11% / 24 s reported for participants of a similar training status who engaged in two bouts of T LIM cycling at 110% W PEAK (Higgins et al. 2014 It is important to acknowledge that there are some limitations to our study.
Firstly, the present study examined the effects of expectancy related to an oral bolus solution ingested 60 min prior to exercise. This method was chosen because NaHCO 3 based solutions are widely used in contemporary research (Higgins et al. 2013; McClung and Collins 2007; Price and Simons 2010) . In contrast NaHCO 3 is also often administered via capsules and/or ingestion is staggered over multiple dosages (Carr et al. 2011; Krustrup et al. 2015 
